|
SENP8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66144875635155E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.28674848554056E-13 |
| Normal-vs-Stage2 |
1.25179977494838E-10 |
| Normal-vs-Stage3 |
1.99840144432528E-15 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.231190E-01 |
| Stage1-vs-Stage3 |
2.436500E-02 |
| Stage1-vs-Stage4 |
3.360100E-04 |
| Stage2-vs-Stage3 |
5.395400E-03 |
| Stage2-vs-Stage4 |
3.362700E-04 |
| Stage3-vs-Stage4 |
1.879800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64124269730337E-12 |
| Normal-vs-AfricanAmerican |
5.67960123376565E-11 |
| Normal-vs-Asian |
5.57331958361829E-12 |
| Caucasian-vs-AfricanAmerican |
6.464400E-01 |
| Caucasian-vs-Asian |
1.828980E-01 |
| AfricanAmerican-vs-Asian |
2.499600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84297022087776E-14 |
| Normal-vs-Female |
1.66966440673377E-12 |
| Male-vs-Female |
5.483400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.89528426075958E-14 |
| Normal-vs-Age(41-60Yrs) |
1.67810210172092E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64157576421076E-12 |
| Normal-vs-Age(81-100Yrs) |
6.33509999999893E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.618400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.558000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.800200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.964600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.283400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.168200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.84634000000017E-05 |
| Classical-VS-Follicular |
3.484600E-01 |
| Classical-VS-Other |
5.834200E-01 |
| Classical-VS-Normal |
1.86406445834564E-13 |
| Tall-VS-Follicular |
1.88433999999127E-05 |
| Tall-VS-Other |
1.574780E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.221600E-01 |
| Follicular-VS-Normal |
2.35444996832257E-12 |
| Other-VS-Normal |
2.592900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.34319247233361E-13 |
| Normal-vs-N1 |
4.44089209850063E-16 |
| N0-vs-N1 |
5.615100E-03 |
|
|
